Reorg hosted a webinar on Aug. 14 in which panelists provided an analysis of the U.S. Supreme Court’s Purdue Pharma decision, which outlawed nonconsensual nondebtor releases in Chapter 11 plans. The discussion covered the implications of the decision for practitioners, particularly in mass tort bankruptcies and beyond, as well as how courts are already reacting to the ruling.
Complete the form below to watch the webinar replay:
Reorg Headquarters: 11 East 26th Street, 12th Floor, New York, NY 10010 | Copyright © 2024, all rights reserved. Reorg is a registered trademark of Reorg Research, Inc. | Terms & Conditions | Privacy Policy |
